Harris’ Health Priorities Could Take More Progressive Stance Than Biden
July 22, 2024
Morning Briefing
News outlets look at the policies a Kamala Harris platform would champion should the vice president lead the top of the Democratic ticket. Progressives support her more liberal views.
First Edition: July 22, 2024
July 22, 2024
Morning Briefing
Today’s early morning highlights from the major news organizations.
Rescue From Above: How Drones May Narrow Emergency Response Times
By Michelle Andrews
July 22, 2024
KFF Health News Original
Public safety and health care organizations are using drones to speed up lifesaving treatment during medical emergencies in which every second counts.
Rescate desde el cielo: cómo los drones pueden reducir el tiempo de respuesta a una emergencia
By Michelle Andrews
July 22, 2024
KFF Health News Original
Cada año más de 356,000 personas sufren un paro cardíaco fuera de un hospital. Cada minuto que pasa sin intervención médica disminuye las probabilidades de supervivencia en un 10%.
Harris, alguna vez la voz de Biden sobre el aborto, tendría un enfoque abierto en temas de salud
By Stephanie Armour and Julie Appleby and Julie Rovner
July 21, 2024
KFF Health News Original
Mientras los demócratas reconstruyen su candidatura presidencial a pocos meses de las elecciones, se esperaría que, de ser la nueva nominada, Harris adoptase una postura agresiva en apoyo al acceso al aborto y en otros temas controversiales de salud.
Harris, Once Biden’s Voice on Abortion, Would Take an Outspoken Approach to Health
By Stephanie Armour and Julie Appleby and Julie Rovner
July 21, 2024
KFF Health News Original
If she grabs the baton from President Joe Biden to become the new presumptive Democratic presidential nominee, Kamala Harris would widely be expected to take an aggressive stance in support of abortion access — hitting former President Donald Trump on an issue that could undermine his chances of victory.
Biden Ends Presidential Run, Endorses Harris
July 21, 2024
Morning Briefing
News outlets cover President Joe Biden’s historic decision to end his campaign for re-election, which he announced Sunday. Biden also voiced his support for Vice President Kamala Harris to become the party’s nominee.
Journalists Discuss Abortion in GOP Platform and How Idaho’s Ban Drove Away OB-GYNs
July 20, 2024
KFF Health News Original
KFF Health News and California Healthline staff made the rounds on national and local media in the last couple of weeks to discuss topical stories. Here’s a collection of their appearances.
Biden Administration Tightens Broker Access to Healthcare.gov To Thwart Rogue Sign-Ups
By Julie Appleby
July 19, 2024
KFF Health News Original
The Centers for Medicare & Medicaid Services said it has received more than 200,000 complaints in the first six months of the year about people being signed up for Obamacare plans or switched to new plans without their consent.
En la convención republicana de Trump se escuchó poco y nada sobre atención de salud
By Phil Galewitz
July 19, 2024
KFF Health News Original
La atención médica constituye la mayor parte del presupuesto federal, casi $2 mil millones, así como el 17% de la producción económica del país.
At Trump’s GOP Convention, There’s Little To Be Heard on Health Care
By Phil Galewitz
July 19, 2024
KFF Health News Original
Republicans were once the party of Obamacare repeal and abortion opposition. They’ve said little about either issue in Milwaukee.
Viewpoints: Supreme Court Dismissing EMTALA Case Is Dangerous; PBMs Aren’t Lowering Drug Prices
July 19, 2024
Morning Briefing
Editorial writers discuss reproductive health care, prescription drug costs, and addiction treatment.
Little Health Chatter At Republican Convention
July 19, 2024
Morning Briefing
News outlets fact check the few health-related statements made during Day 4 of the Republican National Convention, including in presidential nominee Donald Trump’s speech. On the other side of the ticket, eyes are fixed on Delaware where President Joe Biden contemplates his future.
Republicans Tempered Talk About Abortion
July 19, 2024
Morning Briefing
After Republican nominee Donald Trump pared back the party’s platform to take attention off his celebrated achievement of overturning Roe v. Wade, Republican National Convention speakers pivot to other topics this week. More news about abortion and women’s health comes from Florida, Kansas, Mississippi, and Alabama.
Health Care Among Industries Struck By Global Technology Outage
July 19, 2024
Morning Briefing
A widespread computer error, which began in the middle of the night, is forcing PCs to repeatedly crash with the fabled Microsoft “blue screen of death” issue. Measles, bird flu, and the summer covid surge also are in the news.
HIV Success: Stem Cell Transplant Cured Infection In German Patient
July 19, 2024
Morning Briefing
While celebrating the breakthrough, experts caution that this type of treatment might not help everyone and that more study is needed. Meanwhile, a pregnant woman’s diet could be linked to her child’s autism risk, research suggests.
San Francisco Cancer Research Nonprofit Gains $125 Million Donation
July 19, 2024
Morning Briefing
The Parker Institute of Cancer Immunotherapy will distribute the funds from tech executive Sean Parker and other philanthropists over the next five years to boost cancer research. Abbott Laboratories, Boehringer-GoodRx, Sidecar Health, and more are also in the news.
‘Very Aggressive’ Crackdown On SF Homeless Camps Set For August
July 19, 2024
Morning Briefing
The U.S. Supreme Court just three weeks ago granted cities power to evict unhoused people from encampments. More health industry news comes from New York, Massachusetts, Montana, and more.
Morning Briefing for Friday, July 19, 2024
July 19, 2024
Morning Briefing
The Republican convention, the ACA, abortion access, tech outages, HIV success, cancer, homeless crackdown, covid, and more are in the news.
Psychedelic Mushroom Candies Include Illegal Hallucinogens, Testing Finds
July 19, 2024
Morning Briefing
Virginia consumers, including a 3-year-old child, have been falling ill after ingesting products that contain substances that they should not. Also in the news: MDMA clinical trials and cannabis sales.